分类: health

  • More than 5,000 die from Ebola in DR Congo’s deadliest outbreak

    More than 5,000 die from Ebola in DR Congo’s deadliest outbreak

    Official data released by the Democratic Republic of Congo’s (DRC) national health authorities confirms that the ongoing Ebola outbreak has claimed more than 5,000 lives, marking the deadliest Ebola emergency ever recorded in the country’s history. First detected in May, the outbreak had already outstripped the 2018–2020 Ebola crisis that killed 2,299 people by August this year, with a current case fatality rate standing at 48.6% across 10,300 confirmed cases distributed in 8 of the country’s 26 provinces.
    The epicentre of the crisis remains in north-eastern Ituri province, a long-running active conflict zone where restricted movement and fragmented access to communities have severely hindered standard virus containment efforts. Compounding these operational barriers, widespread misinformation among local populations has triggered a wave of violent attacks against frontline responders: earlier this week, a nurse was killed and a second health worker sustained critical injuries while responding to an Ebola alert, after local youth falsely accused medical teams of contaminating local water supplies and deliberately spreading the virus. Last month, a local politician was beaten to death by crowds for advocating evidence-based Ebola prevention measures, and the Red Cross documented 11 separate violent incidents in the outbreak’s first 100 days that left volunteers injured and an emergency ambulance burned to the ground.
    This 17th recorded Ebola outbreak in DRC’s history is classified as the second largest global Ebola emergency on record, trailing only the catastrophic 2014–2016 West African outbreak that killed over 11,325 people and spread as far as Europe and the United States. United Nations officials warn that the current DRC outbreak is claiming lives at a far accelerated pace compared to prior large-scale events. The pathogen driving the current crisis is the Bundibugyo Ebola species, for which no pre-approved vaccine or targeted therapeutic treatment is currently available, though multiple candidate vaccines are now in active clinical trial phases alongside expanded diagnostic testing and supportive care rollouts.
    Cross-border transmission has already been documented across the region: Uganda recorded 20 confirmed cases and 2 fatalities in the early months of the outbreak, with no new cases reported since August, though targeted travel screening and entry restrictions remain in place for all travellers arriving from DRC. Kenya has confirmed 9 cases and 2 deaths linked to the outbreak, while Nigeria’s national disease control agency announced two new suspected cases over the weekend that are now in isolation and undergoing diagnostic testing, following a confirmed Ebola case in October that was medically evacuated to Switzerland for advanced care. Public health authorities have sought to calm global concern, with the European Centre for Disease Prevention and Control stating that the risk of infection for populations across the European region remains extremely low.
    The World Health Organization’s Africa regional office has issued an urgent call for scaled-up core public health interventions, unimpeded humanitarian access to conflict-affected communities, and expanded trusted community outreach initiatives to counter misinformation and bring the outbreak under control. Ebola is a rare, highly virulent viral disease that causes sudden onset of severe symptoms including fever, vomiting, diarrhoea, and in some cases internal and external bleeding, often progressing rapidly to organ failure, and spreads exclusively via direct contact with the bodily fluids of infected individuals.

  • US Health Secretary RFK Jr to expand access to unapproved peptides

    US Health Secretary RFK Jr to expand access to unapproved peptides

    US Department of Health and Human Services Secretary Robert F. Kennedy Jr. has formally tabled new regulatory proposals that would roll back existing restrictions on a set of highly controversial, unapproved peptides, a move that bypasses the standard Food and Drug Administration rulemaking process and has raised alarms among public health experts. The draft framework, published for public review in the US Federal Register this Wednesday, would grant licensed compounding pharmacies explicit permission to manufacture and dispense six widely circulated peptides that have never completed full FDA safety and efficacy testing: BPC-157, TB-500, KPV, MOTS-c, Semax, and a sixth unlisted formulation, allowing pharmacies to combine these substances into custom compounded medications for consumer access. In a marked break from longstanding administrative protocol, the draft rule originated directly from Kennedy’s executive office rather than the FDA’s internal regulatory team, a departure that has drawn scrutiny from public health observers. Following its full official publication later this week, the proposal will open a 14-day window for public feedback before final review. The policy shift follows a narrow July vote by an FDA external advisory panel that supported loosening curbs on these six substances, even as the agency’s own full-time career scientific staff formally recommended against the change, citing insufficient safety data. Kennedy has openly stated he is a vocal proponent of these peptide products, and previously pledged to roll back regulatory barriers targeting the booming unregulated peptide market that the Biden administration moved to crack down on in its final months in office. Peptides are naturally occurring short chains of amino acids, functioning as cellular messengers that support core bodily processes ranging from immune response to hormone balance and skin maintenance; regulated, rigorously tested peptide formulations such as insulin have been standard of care for diabetes management for over 100 years. However, a largely unregulated wellness market for untested peptides has exploded in popularity in recent years, driven by the mainstream success of GLP-1 weight loss peptide drugs. Social media influencers across platforms including TikTok have heavily marketed bundled peptide “stacks” for a range of unproven, off-label benefits, touting them as fast-acting remedies for anti-aging, rapid injury healing, and skin improvement. The trend has particularly taken root among teenage boys on TikTok, who have embraced untested peptides as part of viral “biohacking” and “looksmaxxing” trends that falsely claim the substances can deliver accelerated muscle growth. Leading medical and public health experts have repeatedly issued stark warnings against the unmonitored use of these unapproved peptides, emphasizing that none of the six substances covered by Kennedy’s proposal have completed comprehensive human clinical trials, leaving their long-term health impacts, potential side effects, and safe dosing parameters entirely unknown. The BBC has reached out to the FDA for an official statement on the unprecedented proposed rule change, as stakeholders across the public health and pharmacy sectors prepare to submit feedback during the upcoming public comment period.

  • Australian sunscreen brands face stricter rules after safety scandal

    Australian sunscreen brands face stricter rules after safety scandal

    Against the backdrop of Australia holding the unenviable title of the world’s highest national skin cancer incidence rate, the country’s therapeutic regulator has rolled out a suite of tightened, industry-wide rules for sunscreen manufacturers in direct response to a widespread public safety scandal that triggered nationwide consumer outrage. Announced Tuesday by the Therapeutic Goods Administration (TGA), the new regulatory framework introduces far more rigorous testing protocols and stricter quality control mandates for key active ingredients in sun care products, following a damning 2025 investigation from leading Australian consumer advocacy group Choice. Published in June 2025, the Choice audit tested 20 popular, widely sold sunscreen SKUs – including multiple high-priced premium lines – and found 16 of the 20 products failed to deliver the level of sun protection factor (SPF) advertised on their packaging. The most egregious discrepancy involved Ultra Violette’s Lean Screen Skinscreen, a product marketed as offering SPF 50+ maximum protection, which independent testing revealed only delivered an SPF of 4, prompting a full voluntary recall of the item last year. In the aftermath of the scandal, more than a dozen separate sun care products were either pulled from retail shelves entirely or hit with immediate sales suspension orders, as public trust in Australia’s once widely trusted sunscreen sector collapsed. TGA Chief Media Adviser Robyn Langham explained to the BBC that the core objective of the proposed reforms is to eliminate ambiguity around SPF claims, and grant the regulator expedited access to supporting evidence as soon as potential safety or performance concerns emerge. “Australians have every right to expect that the SPF number printed on a sunscreen bottle is backed by unassailable, rigorous proof,” Langham noted in an official emailed statement. “These proposed reforms center that public expectation at the very core of our sunscreen regulatory regime, imposing stricter testing requirements for the exact finished product consumers take home, plus mandatory repeated performance testing for as long as a product remains on the open market.” Additional guardrails in the new rules will restrict the maximum SPF claims that can be printed on cosmetic products that include incidental UV protection, a provision designed to draw a clear, unambiguous line for shoppers between dedicated sunscreens formulated primarily for UV defense, and beauty items where sun protection is a secondary, secondary add-on feature. Regulators are also formalizing a new mandate that will require all sunscreen suppliers to submit full SPF testing data directly to the TGA at the time they list a new product for sale in the Australian market. The TGA confirmed the full suite of reforms will be rolled out in phased stages, with additional targeted public and industry consultations scheduled for measures that require further refinement. The regulator noted that previously floated plans to simplify and standardize sunscreen packaging labelling will be rolled out at a later date, following an extended period of stakeholder review. Consumer advocacy group Choice issued a formal statement Tuesday welcoming the TGA’s new regulatory package, but pushed for one critical additional amendment: rather than restricting SPF test data access exclusively to the TGA, the full test results should be proactively released to the general public and subject to ongoing, routine independent monitoring, a change the group argued is essential to upholding full transparency and protecting public safety.

  • Uganda imposes 21-day quarantine on citizens returning from DR Congo

    Uganda imposes 21-day quarantine on citizens returning from DR Congo

    Uganda’s Ministry of Health has rolled out a suite of enhanced public health restrictions aimed at shielding the East African nation from a catastrophic Ebola outbreak, as a deadly ongoing epidemic in the neighbouring Democratic Republic of Congo continues to spread across regional borders.
    The new rules, formally announced by Health Minister Chris Baryomunsi during a Sunday press briefing, mandate that all Ugandan citizens returning home from DR Congo complete a full 21-day supervised isolation period at their own personal expense. Additionally, no travellers with a recent travel history to DR Congo will be permitted to transit through Ugandan territory, with only a narrow exception carved out for essential cross-border travellers from DR Congo, who will still be subjected to rigorous, multi-layered public health screening protocols before being granted entry. Officials have also ramped up infectious disease screening operations at Entebbe International Airport, every official land border crossing, and a network of newly established designated road checkpoints across the country.
    These tightened safeguards come in the wake of two separate recent Ebola cases in neighbouring Kenya and Nigeria, both involving individuals who transited through Ugandan territory earlier this month. The Kenyan case was a businessman with commercial interests in DR Congo, who tested positive shortly after returning to Nairobi and died only two days after his arrival; his subsequent contacts have led to eight additional confirmed Ebola cases in Kenya, with a second family member of the original patient dying over the past weekend. The Nigerian case is a Ugandan-born spouse of a Swiss diplomat who had travelled to Kampala for a holiday. Regional public health authorities initially stated the Nigerian patient had only transited through Uganda en route from eastern DR Congo, but Ugandan officials confirmed Sunday that they are now collaborating directly with Nigerian health agencies to map her full travel itinerary and identify any potential points of exposure to the virus. Health ministry permanent secretary Diana Atwine also noted that closed-circuit television footage from Entebbe International Airport confirms the two international Ebola patients had no direct physical interaction during their shared day of transit through the facility, eliminating the possibility of cross-transmission between them on Ugandan soil.
    Ugandan health officials emphasized that the country has not recorded any local Ebola transmissions this month, and the World Health Organization formally declared Uganda Ebola-free back in August, shortly after a small cluster of 20 cases and two fatalities emerged in the earliest weeks of the DR Congo outbreak. That ongoing DR Congo outbreak, which began in May, is the deadliest Ebola epidemic ever recorded in the country, having already claimed more than 4,500 lives to date, and has spread to multiple nations beyond DR Congo’s borders.
    The 60 people who were placed under mandatory monitoring after coming into contact with the Kenyan Ebola patient during his transit through Uganda have all been officially cleared and discharged as of the Sunday announcement. Baryomunsi stressed that the new measures are a proactive precaution, noting that Uganda and DR Congo share extensive, porous borders, with communities on both sides deeply interconnected through cross-border trade, regular travel, and extended family networks. The strain of Ebola driving the current regional outbreak is the rare Bundibugyo variant, for which no licensed vaccine or targeted specific treatment is yet available, though multiple clinical trials are currently in progress. Ebola spreads exclusively via direct contact with the infected bodily fluids such as blood, vomit, or other secretions of a symptomatic patient, making targeted screening and quarantine the most effective frontline defences for at-risk border nations.

  • Vanessa Trump says she is cancer-free six months after revealing diagnosis

    Vanessa Trump says she is cancer-free six months after revealing diagnosis

    Vanessa Trump, ex-wife of former U.S. President Donald Trump’s eldest son Donald Trump Jr, has revealed she is fully free of breast cancer months after her public diagnosis earlier this year, sharing the uplifting update via a short, heartfelt video posted to her 19-year-old daughter Kai’s verified Instagram profile on a recent Friday. The 48-year-old mother of five, who separated from Donald Trump Jr in 2018, confirmed in the clip that her latest round of post-treatment medical screenings returned entirely clear results, marking the end of her battle with the illness. The Instagram post served as a teaser for a full-length YouTube documentary-style discussion set to premiere the following Saturday, featuring Vanessa, Kai, and renowned medical expert Dr. Nicole Saphier. The conversation will dive deep into Vanessa’s personal treatment journey, actionable breast cancer prevention strategies, and the life-saving importance of early detection, timed to align with global Breast Cancer Awareness Month observed every October. Kai Trump penned a caption for the post explaining that the special collaborative project was designed to destigmatize conversations around the disease and extend vital support to other families navigating similar diagnoses. The announcement quickly garnered widespread public attention, racking up more than 20,000 likes and hundreds of supportive comments from followers across the U.S., including public well-wishes from celebrated American singer and media personality Mary Millben. Vanessa first shared her breast cancer diagnosis publicly back in May, disclosing that she had already completed surgical intervention at that point and was working closely with her oncology care team to finalize a comprehensive long-term treatment roadmap after first receiving the unsettling news in April. Context from the American Cancer Society underscores the public health urgency of their awareness effort: data shows the average lifetime risk of a woman in the United States developing breast cancer sits at roughly 13%, or 1 in 8, making the condition responsible for 30% of all new cancer diagnoses recorded in women each year. While surgical intervention successfully eradicates the majority of breast cancer cases, residual traces of the disease can be targeted with supplementary treatments including chemotherapy, radiotherapy, and endocrine therapy to drastically reduce the risk of long-term recurrence. Medical innovation in the space has accelerated rapidly in recent years, with new breakthroughs including highly targeted therapies for early-stage breast cancer, next-generation hormonal treatments, and far more precise, less invasive radiotherapy protocols transforming patient outcomes. The public update comes roughly a year after Vanessa Trump made headlines for confirming her new romantic relationship with legendary professional U.S. golfer Tiger Woods.

  • Woman, 65, becomes second patient to die of Ebola in Kenya

    Woman, 65, becomes second patient to die of Ebola in Kenya

    Kenya’s Ministry of Health has confirmed the country’s second Ebola-related fatality, marking a critical update to its first ever recorded outbreak of the viral disease. The 65-year-old deceased woman was an immediate close family contact of the outbreak’s first victim, a Congolese traveller who arrived in Nairobi after seeking treatment at multiple medical facilities across the Democratic Republic of Congo in September, and died on 5 October. The latest fatality had been placed under mandatory quarantine when she first developed symptoms on 13 October, health authorities verified. At present, seven additional Ebola patients are receiving dedicated care across two specialized isolation facilities in the country: three are remaining relatives of the initial index case, three are frontline healthcare workers, and one is a hospital cleaning staff member. The health ministry has stressed that all confirmed cases belong to a single, contained transmission cluster, with zero verified evidence of widespread community spread to date. This outbreak is part of a broader regional crisis that has claimed over 4,000 lives across Africa since Ebola resurfaced in the DRC in May, making it the second deadliest Ebola outbreak in global history. The strain circulating in this cluster is the rare Bundibugyo variant, for which no fully approved vaccine or targeted therapeutic treatment is yet available, though multiple clinical trials are currently ongoing. The International Rescue Committee, which has been collaborating with regional governments to curb transmission, warns that Kenya faces sustained, elevated risk of new imported cases given the DRC’s tally of more than 9,500 total infections. In response, Kenyan authorities have rolled out strict, multi-layered cross-border screening protocols covering travellers arriving from 10 high-risk nations: the DRC, Uganda, Tanzania, Rwanda, Burundi, Angola, Zambia, Ethiopia, South Sudan, and the Central African Republic. All inbound passengers from these countries must complete a digital health surveillance form prior to boarding their flights, and present a corresponding QR code to port health officials for verification upon arrival, while all aircraft originating in the high-risk zones are subject to enhanced disinfection and public health checks. Domestically, the government has launched a widespread public awareness campaign to educate residents on Ebola’s transmission risks, urging prompt reporting of any suspected symptoms and immediate medical care-seeking, alongside guidance on core preventive measures including frequent handwashing and avoiding unprotected close contact with visibly ill individuals. The U.S. State Department has issued an official travel advisory warning its citizens against non-essential travel to Kenya, while neighbouring states including Uganda, Ethiopia, and Somalia have activated their own national public health alert systems to prepare for potential imported cases. In a separate related development, Nigerian Health Minister Professor Ali Pate announced that the single confirmed Ebola case recorded in Nigeria appears to be genetically linked to the strain circulating in Kenya. Pate noted that there is no current evidence that the Kenyan index case travelled to Nigeria directly, though additional confirmatory testing is still underway to clarify transmission links. Investigators are exploring whether Nigeria’s single patient and Kenya’s first deceased case crossed paths at Uganda’s Entebbe International Airport earlier in October, as both are confirmed to have transited through the facility.

  • Nigeria and Kenya Ebola patients may have crossed paths at Uganda airport, officials say

    Nigeria and Kenya Ebola patients may have crossed paths at Uganda airport, officials say

    Public health officials across Africa are working urgently to unpack a critical question: could two separate Ebola infections in Nigeria and Kenya be traced to a shared exposure event at Uganda’s busiest international airport earlier this month?

    The Africa Centres for Disease Control and Prevention (Africa CDC) confirmed Thursday that both patients transited through Entebbe International Airport on October 3, prompting investigators to examine whether viral transmission occurred via shared airport equipment, overlapping movement in terminal spaces, or indirect contact between the two individuals. Dr. Wessam Mankoula, head of emergency preparedness and response at Africa CDC, noted this cross-path exposure remains one of the most plausible working scenarios, but emphasized no definitive connection between the two cases has been confirmed to date.

    The current situation marks a concerning milestone for regional health security: Nigeria is facing its first confirmed Ebola case in over a decade, while Kenya has already logged nine infections and one death linked to the ongoing outbreak originating in the eastern Democratic Republic of Congo (DRC).

    Detailed case accounts have emerged from global and local health authorities. The Nigerian patient is a 42-year-old Ugandan-born woman who resides in Abuja, married to a Swiss diplomat posted to Nigeria, the Swiss foreign ministry confirmed to Reuters. She traveled to Uganda for approximately two and a half weeks, transiting Addis Ababa, Ethiopia for a two-hour stopover before returning to Nigeria on October 3. Four days after arriving in Abuja, she developed characteristic Ebola symptoms, sought care at two private medical facilities, and received a positive test result on October 20. Her husband, who accompanied her on the Uganda trip, remains in isolation with no reported symptoms as of the latest updates, and the World Health Organization (WHO) says the patient is showing steady improvement while receiving targeted care in isolation.

    The Kenyan patient, a man who traveled from the DRC through Uganda before arriving in Nairobi on the same October 3 date, later succumbed to the virus, becoming Kenya’s first recorded Ebola death in this outbreak. While both travelers passed through Entebbe on the same day, investigators have not yet confirmed whether they encountered one another, used the same airport facilities, or had any form of direct or indirect contact. Beyond the airport link, the investigation is also exploring whether both infections can be traced to a single common source outside the airport.

    To date, the exact location of the Nigerian patient’s exposure remains unconfirmed. “The source of exposure is still not known. The travel history of the patient is still being pieced together,” explained Dr. Patrick Otim, a WHO emergency response official. He added that investigators have faced challenges building a full timeline of her movements, as access for interviews has been limited while she receives inpatient care.

    Nigeria’s Centre for Disease Control (NCDC) has prioritized genomic sequencing of the virus sample from the patient, a step that will help scientists determine whether her infection is genetically linked to the ongoing DRC outbreak and the Kenyan cases. “The investigation is reconstructing the full travel and exposure history. Genomic sequencing is given a high priority,” noted Dr. Pavel Ursu, WHO’s representative in Nigeria. While Ugandan officials have previously stated the woman traveled to eastern DRC for business, the epicenter of the current outbreak, WHO, Africa CDC and Nigeria’s health ministry say they have not received verified confirmation of that trip. Ugandan health authorities have repeatedly stressed the country has no confirmed active Ebola cases, and the woman’s transit through the country does not automatically mean she contracted the virus there.

    As the investigation progresses, Nigerian officials have expanded contact tracing efforts beyond the initial 44 people identified as potentially exposed. Mankoula told reporters most of the newly identified exposed individuals are healthcare workers who treated the patient at the two private facilities she visited before her positive test, with a small number of family contacts also added to monitoring lists. Nigerian authorities are currently isolating all high-risk contacts, though Mankoula declined to release an updated total count of monitored contacts ahead of an official government statement. Dr. Ursu confirmed the patient continues to receive high-quality clinical care and her condition remains stable.

    In Kenya, public health authorities are approaching a key milestone this weekend: the first group of quarantined people who may have been exposed to Ebola will be allowed to return to their homes Sunday after completing a 21-day monitoring period with no symptom development. Kenya’s Health Director-General Dr. Patrick Amoth confirmed all nine confirmed infections in the country are directly linked to the index patient who died, with no evidence of sustained community spread detected so far. Even so, he warned “we are not out of the woods,” urging the public to maintain vigilance against the virus without unnecessary panic. The eight remaining confirmed Kenyan cases remain in isolation and are responding well to treatment, he added.

    These cross-border cases have renewed longstanding concerns about Ebola spread across porous African borders, particularly between the DRC and Uganda, where thousands of people cross the shared border every day for trade, work, and family visits. Dr. Otim noted the border is long and poorly secured, with many unofficial crossing points that make comprehensive screening of all travelers impossible. The WHO’s Africa regional director Dr. Mohamed Janabi has called for coordinated “regional vigilance” to counter the outbreak, urging all neighboring countries to strengthen routine disease surveillance, speed up investigation of suspected cases, and prioritize protection for frontline healthcare workers who face the highest exposure risk.

    As a reminder for the public, Ebola is a severe viral pathogen that spreads through direct contact with an infected person’s blood or other bodily fluids, or through contact with contaminated surfaces or equipment. It does not spread through airborne transmission like influenza or the common cold. Symptoms include high fever, extreme muscle weakness, vomiting and diarrhea, and the disease can be fatal in a high share of cases if left untreated. Importantly, infected people are not contagious before they develop symptoms. Global health authorities emphasize that rapid contact tracing, immediate isolation of suspected cases, and early clinical intervention are the most critical steps to prevent large-scale secondary transmission.

  • First human case of Shamonda virus detected in France, officials say

    First human case of Shamonda virus detected in France, officials say

    French public health and agricultural authorities have announced a global public health milestone: the first documented human infection with the Shamonda virus (Shav), a pathogen long known to circulate exclusively among livestock populations, has resulted in a patient death in early October.

    Health officials have emphasized that the case is highly exceptional, occurring in a patient with severe immunocompromise that left their body far more susceptible to unusual pathogens than the general population. At this stage, there is no identified risk of widespread transmission or harm to the public, the agencies confirmed.

    Prior to this event, Shav had never been recorded as causing human infection. The virus, which is primarily transmitted by the bite of infected midges, has for decades circulated among animal populations across Africa and Asia, with cattle being its most common host. Sporadic infections have also been documented in other farmed animals including sheep, goats, alpacas, and horses. Infected livestock typically develop symptoms including elevated body temperature, digestive distress such as diarrhea, and significant reductions in milk output for dairy herds.

    Shav first reached European livestock in late July of this year, following its introduction to the continent. Since the initial detection, the virus has been identified in farm animal populations across multiple European nations, including Ireland, Germany, Italy, Spain, and the British Crown Dependency of Jersey. Local animal cases were first spotted in eastern France – the region where the infected patient is believed to have contracted the virus via midge bite – during the spring of 2020, French authorities confirmed in their Thursday briefing.

    The patient, who was already undergoing treatment for a serious underlying health condition at a hospital in Lyon, developed severe neurological complications that initial investigations have found to be “very likely linked” to the novel Shamonda virus infection. The statement from French health and agriculture departments reiterated that the patient’s pre-existing weakened immune system was a critical factor in their vulnerability to this cross-species infection.

    “Until now, the Shamonda virus was considered non-transmissible to humans,” the official statement noted, pointing out that no human cases had been recorded even after decades of the virus spreading among animal populations in Africa and Asia.

    The European Centre for Disease Prevention and Control (ECDC) has confirmed it is actively monitoring the evolving situation, with ongoing investigations in partnership with French and other European public health agencies to trace how the virus made the jump from animal to human. The ECDC is also working to assess any potential long-term public health implications of this first recorded human infection. The case has already been formally reported to the World Health Organization as global health authorities prepare for any future developments related to the pathogen.

  • Nigeria’s first Ebola patient holidayed in Uganda, officials say

    Nigeria’s first Ebola patient holidayed in Uganda, officials say

    A decades-long Ebola outbreak centered in East Africa has reached Nigeria, with health authorities confirming the country’s first imported case this week and launching an urgent contact-tracing effort to stop the virus from spreading further. The infected patient is a 42-year-old woman, the wife of a Ugandan diplomat based in Nigeria’s capital Abuja, who recently returned from a trip to East Africa.

    According to Dr. Jean Kaseya, head of the Africa Centres for Disease Control and Prevention (Africa CDC), the woman arrived back in Abuja on October 3, and first developed telltale Ebola symptoms three days later on October 6. Nigeria’s Health Minister Muhammad Ali Pate told the BBC she spent two and a half weeks in Uganda’s capital Kampala during her trip, and made a two-hour stopover in Addis Ababa, Ethiopia, on her return journey to Nigeria.

    Initially, the woman sought care at two private hospitals, where medical staff suspected she had malaria — a common endemic illness in Nigeria that shares key early symptoms with Ebola, including fever, muscle aches, and headaches. It was not until October 19, when her condition failed to improve, that public health authorities were alerted. She tested positive for Ebola the following day, after three rounds of laboratory testing. As of this week, Pate says the patient is in stable condition and showing signs of improvement. She has not left Abuja since arriving back in the country, and 44 people who came into contact with her have been identified and placed in isolation. None of the contacts have developed Ebola symptoms to date, according to the minister. “We cast the net wide so that we contain it as broadly as possible,” Pate told the BBC.

    There is currently a public disagreement between Nigerian health officials and the Ugandan Ministry of Health over the details of the patient’s travel history. Earlier statements from Uganda claimed the woman was a Nigerian national who traveled to eastern Democratic Republic of Congo (DRC) for business and only transited through Uganda, adding that there are no active confirmed Ebola cases in Uganda currently. Pate and Kaseya have pushed back against this account, but both have downplayed tensions, emphasizing cross-border collaboration is the priority.

    Kaseya urged all African nations to share transparent, timely information to help investigators trace the woman’s movements and pinpoint where she contracted the virus. He also called on Western nations to avoid imposing broad travel bans, arguing that collaboration and continental solidarity are the most effective tools to curb the ongoing outbreak.

    The current outbreak, which originated in the DRC this past May, has already been linked to more than 9,500 confirmed cases and at least 4,600 deaths, per data from the European Centre for Disease Prevention and Control. After the outbreak was first announced, Uganda reported a small number of cases that left two people dead, but the country declared itself Ebola-free in August following the discharge of its last patient. In recent weeks, the virus has spread further east, with Kenya confirming at least nine infections. On Monday, the U.S. State Department raised its travel advisory for Kenya, urging American citizens to reconsider travel plans to the country due to Ebola-related health risks.

    This outbreak is caused by the rare Bundibugyo strain of Ebola, for which no approved vaccine or specific treatment currently exists, though clinical trials for new countermeasures are ongoing. Unlike many countries in the region, Nigeria has prior experience successfully containing an Ebola outbreak: back in 2014, the country stopped the spread of the virus after recording 20 confirmed cases and eight deaths. Pate expressed confidence that Nigeria can replicate that success today, pointing to strengthened disease surveillance systems, expanded laboratory capacity, and thousands of trained epidemiologists. “Nigeria has muscle memory that has been activated, but we are not fighting the past outbreak in exactly the same way. We have to be vigilant,” he said.

    Currently, there are no rapid, on-demand Ebola tests available to screen cross-border travelers, so public health officials rely on basic temperature monitoring to identify potential cases at ports of entry. Ebola spreads through direct contact with infected bodily fluids such as blood or vomit. The virus has an incubation period ranging from 2 to 21 days, meaning exposed individuals can remain asymptomatic for weeks after contracting the virus, making contact tracing and containment particularly challenging.

  • Is Ebola under control in Kenya after nine cases confirmed?

    Is Ebola under control in Kenya after nine cases confirmed?

    For the first time in its recorded public health history, Kenya is confronting an unprecedented Ebola outbreak – a crisis that neighboring Uganda and the Democratic Republic of Congo have decades of experience managing. To date, nine confirmed cases have been logged, all linked back to the index patient: a Kenyan businessman who traveled out of an Ebola-affected zone in eastern DR Congo, transited two other countries, and died two weeks after crossing into Kenya. Among the new infections are four of the index patient’s relatives, three frontline healthcare workers, and one hospital cleaner.

    Growing public and expert anxiety over potential wider community spread has persisted, even as Kenyan public health officials work continuously to reassure residents that the outbreak remains contained. At a regional level, the ongoing DR Congo Ebola outbreak – the second deadliest on record, with more than 9,500 confirmed cases and over 4,000 deaths since it was declared in May – creates a persistent cross-border risk of new imported cases for Kenya, which acts as a major regional transport and trade hub. The current outbreak is caused by the rare Bundibugyo Ebola species, for which no widely approved vaccine or targeted treatment exists, though clinical trials for new countermeasures are currently ongoing.

    From the moment the first case was confirmed, Kenyans have questioned why the index patient was able to travel unimpeded through multiple countries after spending time in eastern DR Congo’s high-risk Ebola zone before his infection was detected. Kenya’s national doctors’ union, the Kenya Medical Practitioners and Dentists Union (KMPDU), has raised alarms over systemic lapses in screening at key border crossings with Uganda and Tanzania, as well as at Nairobi’s Jomo Kenyatta International Airport. Union representative Dennis Miskellah confirmed that border and port health facilities are severely understaffed, leaving critical gaps in infection control.

    In spite of these concerns, senior health officials have emphasized steady progress in containing the outbreak. “All eight currently active patients are showing improvement and responding well to care,” Kenya’s Health Director-General Patrick Amoth stated Tuesday, in an effort to calm public panic. Immediately after the first case was announced, authorities rolled out enhanced cross-border screening measures for all travelers arriving from 10 high-risk African nations: DR Congo, Uganda, Tanzania, Rwanda, Burundi, Angola, Zambia, Ethiopia, South Sudan and the Central African Republic. Travelers from these countries must now complete a digital surveillance form before boarding any flight to Kenya and present a scannable QR code to port health officials upon arrival, with all incoming aircraft also subject to enhanced public health inspections.

    Within Kenya’s borders, the government has launched a nationwide public awareness campaign to educate residents on Ebola symptoms and prevention, urging people to immediately report suspected cases and seek prompt hospital care. Core hygiene guidance, including frequent handwashing and avoiding close contact with symptomatic individuals, has been widely distributed. The government has also designated dedicated treatment and isolation facilities across all counties, completed training for nearly 5,000 national and local healthcare workers in Ebola clinical management and infection control, and opened a specialized testing laboratory at Kenyatta National Hospital’s Infectious Disease Unit to prevent cross-contamination of general lab samples.

    Contact tracing efforts have already reached 99% of people known to have been exposed to the index patient, with 134 of 135 identified contacts currently in supervised quarantine. Public health officials from the International Rescue Committee (IRC), which has partnered with both Kenyan and Congolese authorities on outbreak response, note that all confirmed infections to date are directly linked to the index patient – a clear indicator that early containment measures are working effectively. Kenya is also collaborating with global and regional health bodies including the Africa Centres for Disease Control and Prevention and the World Health Organization (WHO) to scale up surveillance, public outreach, and community engagement. A free 24/7 toll-free emergency hotline has been activated to allow residents to report suspected symptoms.

    “None of the traced contacts have developed symptoms before entering quarantine, so the risk of secondary community spread is extremely minimal, effectively non-existent,” Amoth affirmed. Ebola, which spreads through direct contact with infected bodily fluids such as blood or vomit, has an incubation period ranging from 2 to 21 days, meaning exposed individuals can remain asymptomatic for weeks after infection.

    In addition to training and infrastructure upgrades, the Kenyan Ministry of Health has partnered with the WHO to produce public health materials that explicitly address the danger of stigma surrounding the outbreak. Posters distributed across the country carry the message: “Stop stigma, choose support. Stigma can discourage people from reporting symptoms or cooperating with response teams.” Authorities have also called on Kenyans to avoid discriminating against contacts of confirmed cases. The government has additionally procured stockpiles of personal protective equipment (PPE) for frontline facilities.

    However, KMPDU has pushed back on the government’s claims of adequate preparedness, pointing to the infection of three healthcare workers and one hospital cleaner as evidence of unaddressed gaps in worker protection. Frontline health staff face inherently higher risk of infection, as they regularly come into contact with infected patients’ bodily fluids during care. “Protective equipment must be distributed to all hospitals to ensure full worker protection, especially in cases where symptomatic patients do not disclose recent travel to high-risk Ebola zones,” Miskellah told the BBC. He also called for expanded public health education to reduce stigma, so that people with potential exposure do not hide their symptoms. The IRC has additionally called for sustained international funding to support contact tracing, border screening, and ongoing frontline worker training in Kenya.

    To date, the Kenyan government has rejected calls for national lockdowns, internal travel restrictions, or bans on public gatherings and trade, and the country remains open to international visitors. No nation has implemented a full travel ban on Kenya, though the U.S. has issued an advisory urging its citizens to reconsider non-essential travel to the country over Ebola concerns. The UK has issued a health alert warning British travelers that they will face enhanced screening upon entry to Kenya, while Canada has advised its citizens returning from Kenya to monitor their health for 21 days after arrival. Regional neighbors have also activated their own precautionary measures: one contact of the index patient is currently quarantined in Somalia, with samples sent to Nairobi for testing, while Somalia, Ethiopia, Tanzania, and Uganda have all tightened border surveillance and screening for incoming travelers. Uganda, which was declared Ebola-free by the WHO after a small 2022 outbreak, continues to maintain strong border monitoring to prevent reintroduction of the virus.

    Public health and economic analysts have flagged potential risks to Kenya’s key international tourism sector if the outbreak spreads to the general community, but so far there is no empirical evidence of a major drop in travel demand. Cross-border population movement between eastern DR Congo and Kenya remains frequent: a 2022 report from the Center for Strategic and International Studies estimates that roughly 2,500 Kenyans live in eastern DR Congo, while more than 10,000 Congolese reside in Nairobi alone. Kenya’s embassy in Kinshasa has long urged Kenyans living in the high-risk region to register with the mission to facilitate emergency support if needed.